Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes
NCT ID: NCT01776099
Last Updated: 2020-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2012-11-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The DiNA study prospectively investigates, if non-soluble non-fermentable fibers (vs. soluble ones) and galactose (vs. palatinose) are capable to improvement metabolic parameters in patients with long-term type 2 diabetes and intensive insulin treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of (1,3), (1,6)-Beta-D-glucan on Insulin Sensitivity and Inflammatory Markers of the Metabolic Syndrome
NCT00403689
The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes
NCT04509245
Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
NCT03552991
Fiber Mix and Glycemic Response
NCT03334643
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
NCT01375803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pure galactose
5 grams of galactose, three times a day with the main meals, duration: 4 weeks
Dietary supplement (4 arms, 2 active, 2 placebo)
pure palatinose
5 grams of palatinose, three times a day with the main meals, duration: 4 weeks
Dietary supplement (4 arms, 2 active, 2 placebo)
soluble non-fermentable fibers
5 grams of soluble non-fermentable fibers, three times a day with the main meals, duration: 4 weeks
Dietary supplement (4 arms, 2 active, 2 placebo)
non-soluble non-fermentable fibers
5 grams of non-soluble non-fermentable fibers, three times a day with each main meal, duration: 4 weeks
Dietary supplement (4 arms, 2 active, 2 placebo)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary supplement (4 arms, 2 active, 2 placebo)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* high insulin resistance
Exclusion Criteria
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Firma Rettenmeier & Söhne (Company)
UNKNOWN
German Center for Diabetes Research
OTHER
German Institute of Human Nutrition
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Andreas F. H. Pfeiffer
Director of the Department for Clinical Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas F.H. Pfeiffer, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
German Institute for Human Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité-Klinikum Benjamin Franklin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DiNA-S DiNA-F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.